Bryan Williams

Bryan Williams

Director/Board Member bei PACIFIC EDGE LIMITED

Vermögen: 31 031 $ am 31.03.2024

74 Jahre
Consumer Services
Health Technology
Commercial Services

Profil

Bryan Raymond George Williams is currently the Chief Executive Officer & Director at MIMR-PHI Institute of Medical Research and the Chairman at BioGrid Australia Ltd.
He is also an Independent Non-Executive Director at Pacific Edge Ltd.
and a Director at Cancer Trials Australia, Hudson Institute of Medical Research, Pacific Edge Diagnostics Singapore Pte Ltd., Xynapse Therapeutics Pty Ltd., and Cartherics Pty Ltd.
Previously, he served as the Chief Executive Officer & Director at Hudson Institute of Medical Research, Non-Executive Chairman at MEI Pharma, Inc., and Chairman-Department of Cancer Biology at Cleveland Clinic Lerner Research Institute and The Cleveland Clinic Foundation.
He was also the Global Director-Organizational Effectiveness at The Ritz-Carlton Hotel Co. LLC.
Additionally, he served as the Director at Monash Institute of Medical Research and Pacific Edge Pty Ltd.
He has also held positions as a Professor-Department of Genetics at Case Western Reserve University and an Adjunct Professor at Cleveland State University and Kent State University (Ohio).
Dr. Williams received his undergraduate and doctorate degrees from the University of Otago.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
04.08.2023 610 357 ( 0,08% ) 31 031 $ 31.03.2024

Aktive Positionen von Bryan Williams

UnternehmenPositionBeginn
PACIFIC EDGE LIMITED Director/Board Member 04.07.2013
Cancer Trials Australia Director/Board Member -
Cartherics Pty Ltd. Director/Board Member -
Xynapse Therapeutics Pty Ltd. Director/Board Member -
Pacific Edge Diagnostics Singapore Pte Ltd. Director/Board Member -
BioGrid Australia Ltd. Chairman -
MIMR-PHI Institute of Medical Research Chief Executive Officer -
Director/Board Member -
Alle aktiven Positionen von Bryan Williams

Ehemalige bekannte Positionen von Bryan Williams

UnternehmenPositionEnde
Chief Executive Officer 01.01.2017
░░░ ░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Bryan Williams im Detail an

Ausbildung von Bryan Williams

University of Otago Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Bryan Williams im Detail an

Beziehungen

99

Beziehungen ersten Grades

18

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
PACIFIC EDGE LIMITED

Health Technology

MEI PHARMA, INC.

Health Technology

Private Unternehmen12

Consumer Services

Commercial Services

Health Services

Cancer Trials Australia

Monash Institute of Medical Research

Pacific Edge Pty Ltd.

MIMR-PHI Institute of Medical Research

BioGrid Australia Ltd.

Commercial Services

Pacific Edge Diagnostics Singapore Pte Ltd.

Xynapse Therapeutics Pty Ltd.

Cartherics Pty Ltd.

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Bryan Williams